Lung cancer is the leading cause of cancer death – 1.76 million lung cancer deaths occurred worldwide in 2018. More than 80% of patients
were presenting with non-small cell lung cancer (NSCLC). Both NSCLC and small cell lung cancer (SCLC) are still frequently diagnosed
at advanced stage. Maxim Kosov, Daniella Bajzath, Kamen Doxev and Maxim Belotserkovskiy at PSI CRO AG expand upon the serious adverse events that can occur in lung cancer clinical trials.